Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126695571 | 12669557 | 1 | I | 2016 | 20160809 | 20160819 | 20160819 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52243BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126695571 | 12669557 | 1 | PS | TRADJENTA | LINAGLIPTIN | 1 | Oral | 5 MG | 201280 | 5 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 2 | SS | TRADJENTA | LINAGLIPTIN | 1 | Oral | 201280 | TABLET | QOD | |||||||||
| 126695571 | 12669557 | 3 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 126695571 | 12669557 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG | 0 | 1000 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG | 0 | 500 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 6 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 7 | C | ZOCOR | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126695571 | 12669557 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 9 | C | Nefedipine | 2 | Oral | 30 MG | 0 | 30 | MG | TABLET | QD | |||||||
| 126695571 | 12669557 | 10 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 11 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | Oral | 30 MG | 0 | 30 | MG | TABLET | QD | ||||||
| 126695571 | 12669557 | 12 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126695571 | 12669557 | 13 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126695571 | 12669557 | 1 | Type 2 diabetes mellitus |
| 126695571 | 12669557 | 3 | Product used for unknown indication |
| 126695571 | 12669557 | 4 | Type 2 diabetes mellitus |
| 126695571 | 12669557 | 6 | Blood cholesterol increased |
| 126695571 | 12669557 | 7 | Blood triglycerides increased |
| 126695571 | 12669557 | 8 | Hypertension |
| 126695571 | 12669557 | 9 | Hypertension |
| 126695571 | 12669557 | 10 | Depression |
| 126695571 | 12669557 | 11 | Anxiety |
| 126695571 | 12669557 | 12 | Depression |
| 126695571 | 12669557 | 13 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126695571 | 12669557 | Blood glucose abnormal | |
| 126695571 | 12669557 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126695571 | 12669557 | 1 | 2015 | 0 | ||
| 126695571 | 12669557 | 4 | 1980 | 0 | ||
| 126695571 | 12669557 | 9 | 2005 | 0 | ||
| 126695571 | 12669557 | 10 | 2011 | 0 | ||
| 126695571 | 12669557 | 11 | 2010 | 0 | ||
| 126695571 | 12669557 | 13 | 2016 | 2016 | 0 |